Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling

[1]  Kenji F. Tanaka,et al.  Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism , 2012, Science.

[2]  T. Südhof,et al.  RIM genes differentially contribute to organizing presynaptic release sites , 2012, Proceedings of the National Academy of Sciences.

[3]  T. Freund,et al.  Multiple functions of endocannabinoid signaling in the brain. , 2012, Annual review of neuroscience.

[4]  B. Alger.  Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know , 2012, The Journal of physiology.

[5]  Thomas C. Südhof,et al.  Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function , 2011, Proceedings of the National Academy of Sciences.

[6]  T. Südhof,et al.  An autism‐associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor‐mediated synaptic transmission in hippocampus , 2011, The EMBO journal.

[7]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[8]  B. Alger,et al.  Supply and demand for endocannabinoids , 2011, Trends in Neurosciences.

[9]  Chiayu Q. Chiu,et al.  Long-term plasticity at inhibitory synapses , 2011, Current Opinion in Neurobiology.

[10]  S. Löwel,et al.  Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina , 2011, Proceedings of the National Academy of Sciences.

[11]  P. Taylor,et al.  Folding anomalies of neuroligin3 caused by a mutation in the alpha/beta-hydrolase fold domain. , 2010, Chemico-biological interactions.

[12]  Robert J. Morgan,et al.  Regulation of Fast-Spiking Basket Cell Synapses by the Chloride Channel ClC–2 , 2010, Nature Neuroscience.

[13]  T. Freund,et al.  Distinct synaptic properties of perisomatic inhibitory cell types and their different modulation by cholinergic receptor activation in the CA3 region of the mouse hippocampus , 2010, The European journal of neuroscience.

[14]  M. Todorova,et al.  Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1 , 2010, The European journal of neuroscience.

[15]  B. Alger,et al.  Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses , 2010, Nature Neuroscience.

[16]  S. Masino,et al.  Control of Cannabinoid CB1 Receptor Function on Glutamate Axon Terminals by Endogenous Adenosine Acting at A1 Receptors , 2010, The Journal of Neuroscience.

[17]  Thomas C. Südhof,et al.  LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation , 2009, Neuron.

[18]  T. Südhof,et al.  Neuroligin-2 Deletion Selectively Decreases Inhibitory Synaptic Transmission Originating from Fast-Spiking but Not from Somatostatin-Positive Interneurons , 2009, The Journal of Neuroscience.

[19]  T. Südhof,et al.  Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments , 2009, Proceedings of the National Academy of Sciences.

[20]  M. Hoon,et al.  Neuroligin 2 Drives Postsynaptic Assembly at Perisomatic Inhibitory Synapses through Gephyrin and Collybistin , 2009, Neuron.

[21]  T. Südhof,et al.  A Neuroligin-4 Missense Mutation Associated with Autism Impairs Neuroligin-4 Folding and Endoplasmic Reticulum Export , 2009, The Journal of Neuroscience.

[22]  T. Südhof.  Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.

[23]  István Katona,et al.  Endocannabinoid signaling as a synaptic circuit breaker in neurological disease , 2008, Nature Medicine.

[24]  P. Somogyi,et al.  Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations , 2008, Science.

[25]  Shiaoching Gong,et al.  Minimal aberrant behavioral phenotypes of neuroligin‐3 R451C knockin mice , 2008, Autism research : official journal of the International Society for Autism Research.

[26]  D. Javitt,et al.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia , 2008, Trends in Neurosciences.

[27]  Lindsey L. Glickfeld,et al.  Complementary Modulation of Somatic Inhibition by Opioids and Cannabinoids , 2008, The Journal of Neuroscience.

[28]  Jacqueline Blundell,et al.  A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice , 2007, Science.

[29]  P. Scheiffele,et al.  Neuroligin‐3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses , 2007, The European journal of neuroscience.

[30]  T. Südhof,et al.  Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2 , 2007, Neuron.

[31]  I. Soltesz,et al.  Postsynaptic origin of CB1‐dependent tonic inhibition of GABA release at cholecystokinin‐positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus , 2007, The Journal of physiology.

[32]  T. Freund,et al.  Perisomatic Inhibition , 2007, Neuron.

[33]  P. Jonas,et al.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks , 2007, Nature Reviews Neuroscience.

[34]  Z. Nusser,et al.  Release Probability-Dependent Scaling of the Postsynaptic Responses at Single Hippocampal GABAergic Synapses , 2006, The Journal of Neuroscience.

[35]  Thomas C. Südhof,et al.  Neuroligins Determine Synapse Maturation and Function , 2006, Neuron.

[36]  I. Soltesz,et al.  Presynaptic, Activity-Dependent Modulation of Cannabinoid Type 1 Receptor-Mediated Inhibition of GABA Release , 2006, The Journal of Neuroscience.

[37]  Jozsef Csicsvari,et al.  Complementary Roles of Cholecystokinin- and Parvalbumin-Expressing GABAergic Neurons in Hippocampal Network Oscillations , 2005, The Journal of Neuroscience.

[38]  M. Low,et al.  Differential Regulation of Synaptic Inputs by Constitutively Released Endocannabinoids and Exogenous Cannabinoids , 2005, The Journal of Neuroscience.

[39]  Ann Marie Craig,et al.  Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins , 2004, Cell.

[40]  Attila Losonczy,et al.  Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Jamain,et al.  Neuroligin 2 is exclusively localized to inhibitory synapses. , 2004, European journal of cell biology.

[42]  R. Angus Silver,et al.  Estimation of nonuniform quantal parameters with multiple-probability fluctuation analysis: theory, application and limitations , 2003, Journal of Neuroscience Methods.

[43]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[44]  Tamás F Freund,et al.  Interneuron Diversity series: Rhythm and mood in perisomatic inhibition , 2003, Trends in Neurosciences.

[45]  B. Cravatt,et al.  Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. , 2003, Current opinion in chemical biology.

[46]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[47]  P. Castillo,et al.  Heterosynaptic LTD of Hippocampal GABAergic Synapses A Novel Role of Endocannabinoids in Regulating Excitability , 2003, Neuron.

[48]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[49]  B. Alger.  Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids , 2002, Progress in Neurobiology.

[50]  R. Nicoll,et al.  Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses , 2001, Nature.

[51]  T. Südhof,et al.  Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Südhof,et al.  Structures, Alternative Splicing, and Neurexin Binding of Multiple Neuroligins (*) , 1996, The Journal of Biological Chemistry.

[53]  T. Südhof,et al.  Neuroligin 1: a splice site-specific ligand for beta-neurexins. , 1995, Cell.

[54]  B. Alger,et al.  Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism , 1994, Neuron.